Searched for
GLENMARK RESULTS
Laurus Labs, Biocon, Ather Energy, Lenskart among probable MSCI India Standard Index inclusion candidates, says JM FinancialJM Financial anticipates significant shifts in the MSCI India Standard Index. Laurus Labs and Biocon are flagged as high-probability additi...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Bank Nifty near key resistance zone; breakout above 54,300 crucial: Ajit MishraIndian equity markets are consolidating within a narrow range, with Nifty struggling to break 24,000 and Bank Nifty showing relative streng...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Buy the dip, but avoid IT, back pharma & power, says Rudramurthy BVIndian markets are experiencing a healthy correction, according to Vachana Investments' MD, CA Rudramurthy BV. He advises waiting for speci...
- Glenmark Pharma Q2 Results: Co posts Rs 355 crore net profit on robust sales growthGlenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net los...
- Glenmark Pharma Q4 Results: Net loss widens to Rs 121 crore YoYGlenmark Pharma Q4 Results: The rise in loss was on account of declining sales in the US and exceptional items. It had reported a net loss ...
- Glenmark reports Rs 403 crore loss in Q4FY23For the fourth quarter of FY23, Glenmark’s consolidated revenue was at Rs. 3374 crore as against Rs.3019 crore in the same quarter of previ...
- Glenmark Q2 Results: Net profit rises 1.4% YoY to Rs 278 croreRevenues rose 7.2% YoY to Rs 3,375 crore during Q2FY23 as against Rs 3,147 crore in Q2FY22
- Glenmark Pharma Q2 results: Net profit rises 17% to Rs 275 crIts consolidated revenue from operations during July-September 2021 stood at Rs 3,147.44 crore. It was Rs 2,952.47 crore for the same perio...
- Study shows Favipiravir provides multiple benefits in COVID-19 treatment: GlenmarkThe Phase 3 study with Favipiravir, sold under the brand name FabiFlu, by the company was conducted in 150 patients, it added. Favipiravir ...
- Glenmark drops 6% as Q2 net profit declinesThe stock has nearly trebled from its March lows of Rs 168, and is up 39 per cent year-to-date.
- Favirpiravir yet to find favour with ICMRHowever, the experts were not convinced and decided not to put it in the revised treatment protocol,” a person aware of the matter told ET ...
- Glenmark Q3 profit zooms 64% to Rs 191 crore; firm to raise $400 millionRevenue stood at Rs 2,735.56 crore against Rs 2,555.04 crore last year.
- Glenmark Pharma's net profit at Rs 78 crore in June quarterThe firm had posted a net profit of Rs 208.58 crore during the same period of previous fiscal, Glenmark Pharma said.
- Glenmark Pharmaceuticals dips nearly 7% on disappointing Q3 nosReacting to the weak numbers, shares of the company opened the day on a weak note and later lost 6.64 per cent to Rs 291.40 on the BSE.
- Glenmark takes 17% knock, biggest in 2 monthsGlenmark, one of the top 10 pharma companies in India by market capitalisation, witnessed a sharp fall of 17% in its intra-day stock price ...
Load More
